US › Healthcare

Innovative Eyewear Inc. (LUCY)

US · Healthcare · Medical Instruments & Supplies

$0.74+8.70%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$773,561
Revenue YoY
+70.2%
Net profit
$-2.3M
Profit YoY
-29.8%
EPS
$-0.37
EPS estimate
$-0.47
Net margin
-298.5%

EPS came in at -0.37 against a street estimate of -0.47 — a beat of 21.3%.

Key statistics

Market cap
$6.0M
Forward P/E
0.0
P/B
0.71
Book value
$1.33
EPS (TTM)
$-1.55
52-week high
$2.27
52-week low
$0.65
50-day MA
$0.88
200-day MA
$1.19
Beta
2.70

Analyst view

Analysts rate Innovative Eyewear Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.00.

Shareholding

Insiders
7.60%
Institutions
9.11%

Largest institutional holders

FundStake
Cetera Investment Advisers7.81%
Geode Capital Management, LLC0.94%
KeyBank National Association0.23%
Tower Research Capital LLC0.03%
JONES FINANCIAL COMPANIES LLLP0.01%
Wells Fargo & Co0.00%
Caitong International Asset Management Co., Limited.0.00%
DRW Securities, LLC0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Innovative Eyewear Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.